Changzhou Qihang Synthetic Biology Venture Capital Fund

Changzhou Qihang Synthetic Biology Venture Capital Fund is an investment firm.

Active

Updated: Feb 28, 2026 ·

About

Changzhou Qihang Synthetic Biology Venture Capital Fund functions as an investment fund dedicated to the synthetic biology industry. Its primary objective is to provide capital to companies operating within this advanced scientific domain, supporting their research, development, and market expansion efforts.

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 4, 2026	Huaguan Biotechnology	$14.4M Series C	—	Changjiang Capital, SDIC Venture Capital, Shunxi Fund, Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise

Financial History

Total Raised

N/A

Valuation

N/A

Deep Dive

The fund has been noted for its participation in significant financing rounds. For instance, it was a joint investor in a funding round for a dark spot-correcting ingredient supplier backed by Proya, as well as in an angel round funding for YouTian Bio. Additionally, it contributed to the Series B funding round for Huaguan Biology.

Changzhou Qihang Synthetic Biology Venture Capital Fund frequently co-invests with other prominent investment firms. Its partners in various funding initiatives have included SoftBank Ventures Asia, Shunxi Fund, SDIC Venture Capital, Guotou, and Yangtze Capital, demonstrating a collaborative approach to venture financing.

Wang Chunping is identified as a partner of the Changzhou Qihang Synthetic Biology Venture Capital Fund, indicating key leadership within the organization. This partnership structure facilitates the fund's investment strategies and portfolio management.

Through its strategic investments, the fund aims to accelerate innovation and commercialization within the synthetic biology ecosystem. Its consistent activity in funding rounds underscores its commitment to nurturing promising ventures in this specialized technological area.

Sources

Frequently Asked Questions

Who are some of the co-investors that Changzhou Qihang Synthetic Biology Venture Capital Fund has partnered with?

The fund has co-invested alongside firms such as SoftBank Ventures Asia, Shunxi Fund, SDIC Venture Capital, Guotou, and Yangtze Capital in various funding rounds.

Does the fund have any known partners?

Yes, Wang Chunping is identified as a partner of Changzhou Qihang Synthetic Biology Venture Capital Fund.